Additional cytogenetic features determine outcome in patients allografted for TP53 mutant acute myeloid leukemia
Sign Up to like & getrecommendations! Published in 2022 at "Cancer"
DOI: 10.1002/cncr.34268
Abstract: The presence of TP53 mutations is associated with an unfavorable outcome in patients allografted for acute myeloid leukemia (AML), leading some to question the benefit of an allogeneic stem cell transplantation (allo‐SCT) for this patient… read more here.
Keywords: additional cytogenetic; myeloid leukemia; patients allografted; acute myeloid ... See more keywords